PATENT CLAIM ANALYSIS

Application Number: 16007464
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "646000"]

Abstract:
A method of treating pain, e.g., acute post-operative pain, by administering to a human patient(s) a therapeutically effective dose of tramadol intravenously in a dosing regimen which includes one or more loading doses administered at shortened intervals as compared to dosing at steady-state is disclosed. In certain embodiments, the dose of tramadol about 25 mg and the second (and optionally) third doses are intravenously administered at intervals of about 2 hours, and thereafter the tramadol is intravenously administered at a dosing interval of about 4 hours, until the patient no longer requires treatment with tramadol.

Claim (Index 5):
The method of  claim 1 , further comprising orally administering about 50 mg to about 100 mg tramadol to the human patients about every 6 hours after the human patients no longer require treatment with intravenous tramadol, until the human patients no longer require treatment with oral tramadol, wherein the tramadol is tramadol base or a pharmaceutically acceptable salt of tramadol.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 94.0
- Lexical Diversity: 1.63636
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15612665', '15622910', '15163111', '14713775', '13445526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779969880639799
- 35 USC 102 Novelty (BERT): 0.608397852670239
- Combined Prediction Score: 0.762812677842843
- Mean Citation Score: 536.4159480000002
- Max Citation Score: 613.0105599999998
- Similarity Product: 448.4026274523162

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test